Design, architect
and execute on clinical trials with AI
with AI
Neuroute
Design, architect
and execute on clinical trials with AI
with AI
Neuroute
Design, architect
and execute
on clinical trials
with AI
Neuroute
Leverage the landscape and your pipeline to accelerate new programs
Understand How the Landscape Relates to Your Pipeline
Turn intelligence into action for early stage portfolio decisions, clinical research & development and commercial planning & analysis.
Streamline Site Selection with Criteria-Based Performance
Assess all relevant sites that have conducted relevant studies based on historical performance. Model performance for your study and connect to ideal collaborators.
Model Enrollment Scenarios with Accuracy
Evaluate patient population, required subject numbers, study duration, competitive landscape, budget considerations, and potential markets. This analysis aids in refining site locations and study design for optimal outcomes.
Leverage the landscape and your pipeline to accelerate new programs
Leverage the landscape and your pipeline to accelerate new programs
Understand How the Landscape Relates to Your Pipeline
Turn intelligence into action for early stage portfolio decisions, clinical research & development and commercial planning & analysis.
Streamline Site Selection with Criteria-Based Performance
Assess all relevant sites that have conducted relevant studies based on historical performance. Model performance for your study and connect to ideal collaborators.
Model Enrollment Scenarios with Accuracy
Evaluate patient population, required subject numbers, study duration, competitive landscape, budget considerations, and potential markets. This analysis aids in refining site locations and study design for optimal outcomes.
Leverage the landscape and your pipeline to accelerate new programs
Leverage the landscape and your pipeline to accelerate new programs
Understand How the Landscape Relates to Your Pipeline
Turn intelligence into action for early stage portfolio decisions, clinical research & development and commercial planning & analysis.
Streamline Site Selection with Criteria-Based Performance
Assess all relevant sites that have conducted relevant studies based on historical performance. Model performance for your study and connect to ideal collaborators.
Model Enrollment Scenarios with Accuracy
Evaluate patient population, required subject numbers, study duration, competitive landscape, budget considerations, and potential markets. This analysis aids in refining site locations and study design for optimal outcomes.
Modus - Immunoglycan for Sepsis
Modus aims to save countless lives using an immunoglycan, Sevuparin, that thins the blood to prevent blood clots without the risk of unwanted bleeding.
Sites Analyzed
174
Studies Analyzed
7,010
Modus - Immunoglycan for Sepsis
Modus aims to save countless lives using an immunoglycan, Sevuparin, that thins the blood to prevent blood clots without the risk of unwanted bleeding.
Indications
8
Studies Analyzed
1,790
Psyrin - Serious mental illness
Psyrin detects serious mental illnesses through AI-powered voice technology. SMIs affect over 145 million people worldwide, reducing expected life expectancy by 15-20 years.
Patient Cohorts
12
Studies Analyzed
4,809
Psyrin - Serious mental illness
Psyrin detects serious mental illnesses through AI-powered voice technology. SMIs affect over 145 million people worldwide, reducing expected life expectancy by 15-20 years.
Indications
150%
Studies Analyzed
1,790
Li Ka Shing Institute of Health Sciences
Scoping the potential of clinical development across indications and countries including Hong Kong, China and the UK.
Indications
21
Studies Analyzed
9,500
Li Ka Shing Institute of Health Sciences
Scoping the potential of clinical development across indications and countries including Hong Kong, China and the UK.
Indications
8
Studies Analyzed
1,790
Input study parameters,
output analytics and actions
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
Input study parameters,
output analytics and actions
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
Input study parameters, output analytics and actions
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
A Model Based on the Association Cortex of the Human Brain
A Model Based on the Association Cortex of the Human Brain
A Model Based on the Association Cortex of the Human Brain
The Science
The Science
The Science
The development and adoption of medicine is inherently complex. However, nature often holds solutions for such complexities, refined through time and evolution.
To enhance clinical development, we must evaluate and associate the criteria for successful studies with the identification of essential contributors and the impact on financial dynamics.
Neuroute is a model of the brain's association cortex for clinical development, effectively merging critical datasets to assist sponsors in reducing the cost of subsequent clinical studies.
The development and adoption of medicine is inherently complex. However, nature often holds solutions for such complexities, refined through time and evolution.
To enhance clinical development, we must evaluate and associate the criteria for successful studies with the identification of essential contributors and the impact on financial dynamics.
Neuroute is a model of the brain's association cortex for clinical development, effectively merging critical datasets to assist sponsors in reducing the cost of subsequent clinical studies.
The development and adoption of medicine is inherently complex. However, nature often holds solutions for such complexities, refined through time and evolution.
To enhance clinical development, we must evaluate and associate the criteria for successful studies with the identification of essential contributors and the impact on financial dynamics.
Neuroute is a model of the brain's association cortex for clinical development, effectively merging critical datasets to assist sponsors in reducing the cost of subsequent clinical studies.
"In partnership with neuroute, we can really change things to the benefit of the patients who still desperately need new and improved medicines."
Dr. Mike Emanuel // Former Head of Clinical Development
"In partnership with neuroute, we can really change things to the benefit of the patients who still desperately need new and improved medicines."
Dr. Mike Emanuel // Former Head of Clinical Development
"In partnership with neuroute, we can really change things to the benefit of the patients who still desperately need new and improved medicines."
Dr. Mike Emanuel // Former Head of Clinical Development
Connecting critical information on clinical trials in limitless ways
Patient Population Analysis
Competitive Landscape
Country Selection
Indication Analysis
Literature Reviews
Protocol Development
Landscape Analysis
Site Selection
Feasibility
Study Design
Site Performance
Audits
Pipeline Review
In-License and Out-License Opportunities
Connecting critical information on clinical trials in limitless ways
Patient Population Analysis
Competitive Landscape
Country Selection
Indication Analysis
Literature Reviews
Protocol Development
Landscape Analysis
Site Selection
Feasibility
Study Design
Site Performance
Audits
Pipeline Review
In-License and Out-License Opportunities
Connecting critical information on clinical trials in limitless ways
Patient Population Analysis
Competitive Landscape
Country Selection
Indication Analysis
Literature Reviews
Protocol Development
Landscape Analysis
Site Selection
Feasibility
Study Design
Site Performance
Audits
Pipeline Review
In-License and Out-License Opportunities
Where AI Meets Medicine
Explore the Future of Clinical Development with Neuroute
Where AI Meets Medicine
Explore the Future of Clinical Development with Neuroute
Where AI Meets Medicine
Explore the Future of Clinical
Development with Neuroute